Get to know our Pipeline
Learn More About our Technology
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape
TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address antigen escape
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity
Bispecific Chimeric Antigen Receptor (CAR) T cells are designed to address autoimmunity
iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors
TGF-β CAR rewires T cell responses to soluble factors to overcome the immune suppressive microenvironment in cancer.
iCAR technology allows specific killing of cancer cells while sparing normal tissue, with potential to treat all solid tumors.
